Literature DB >> 12781779

Explaining the inhibition of glyoxalase II by 9-fluorenylmethoxycarbonyl-protected glutathione derivatives.

Ke-Wu Yang1, Daniel N Sobieski, Anne L Carenbauer, Patrick A Crawford, Christopher A Makaroff, Michael W Crowder.   

Abstract

In an effort to probe the inhibition of glyoxalase II (GLX2-2) from Arabidopsis thaliana, a series of N- and S-blocked glutathione compounds containing 9-fluorenylmethoxycarbonyl (FMOC) and Cbz protecting groups were synthesized and tested. The di-FMOC and di-Cbz compounds were the best inhibitors of GLX2-2 with K(i) values of 0.89+/-0.05 and 2.3+/-0.5 microM, respectively. The removal of protecting groups from either position resulted in comparable, diminished binding affinities. Analyses of site-directed mutants of GLX2-2 demonstrated that tight binding of these inhibitors is not due to interactions of the protecting groups with hydrophobic amino acids on the surface of the enzyme. Instead, MM2 calculations predict that the lowest energy structures of the unbound, doubly substituted inhibitors are similar to those of a bound inhibitor. These studies represent the first systematic attempt to understand the peculiar inhibition of GLX2 by N- and S-blocked glutathiones.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12781779     DOI: 10.1016/s0003-9861(03)00193-0

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  3 in total

1.  Synthesis of azide derivative and discovery of glyoxalase pathway inhibitor against pathogenic bacteria.

Authors:  Benson Edagwa; Yiran Wang; Prabagaran Narayanasamy
Journal:  Bioorg Med Chem Lett       Date:  2013-09-10       Impact factor: 2.823

2.  The metal ion requirements of Arabidopsis thaliana Glx2-2 for catalytic activity.

Authors:  Pattraranee Limphong; Ross M McKinney; Nicole E Adams; Christopher A Makaroff; Brian Bennett; Michael W Crowder
Journal:  J Biol Inorg Chem       Date:  2009-10-16       Impact factor: 3.358

3.  Human glyoxalase II contains an Fe(II)Zn(II) center but is active as a mononuclear Zn(II) enzyme.

Authors:  Pattraranee Limphong; Ross M McKinney; Nicole E Adams; Brian Bennett; Christopher A Makaroff; Thusitha Gunasekera; Michael W Crowder
Journal:  Biochemistry       Date:  2009-06-16       Impact factor: 3.162

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.